Phase II trial finds Chinese COVID-19 vaccine is safe, induces immune response
A phase II clinical trial of a COVID-19 vaccine candidate, conducted in China, has found that it is safe and induces an immune response, a study publ
Full Article
Phase II trial finds Chinese COVID-19 vaccine is safe, induces immune response
Hindu
0 shares
1 views
You might like
Related news coverage
Largest COVID-19 Vaccine Trial Underway
Newsy
Watch VideoThe biggest COVID-19 vaccine study is underway. This week, researchers began testing 30,000 test subjects in the..
Advertisement
More coverage
FTSE 100 shrugs off latest episode in US-China muscle-flexing contest
Proactive Investors
FTSE 100 index gains 35 points Investors sweet on Tate & Lyle after a trading update Unilever hitches its skirts and races higher..
-
FTSE 100 to start Thursday a sliver as traders balance vaccine hopes and US-vs-China fears
Proactive Investors
-
Now China COVID vaccine shows promising result
Mid-Day
-
Support grows for deliberately exposing vaccine trial subjects to COVID-19, with Oxford team leading the way
National Post
-
Lancet: ‘Chinese phase 2 trial finds vaccine safe, induces immune response’
Indian Express